適應症
定量偵測人體血清與血漿中之A型肝炎病毒抗體。  
劑型
 
包裝
ADVIA Centaur HAV Toatl主要試劑組ADVIA Centaur HAV Quality Control Material品管物 
許可證字號
衛部藥製字第021406號 
註銷狀態
註銷日期
 
註銷理由
 
有效日期
2025-08-24  
發證日期
2010-08-24  
許可證種類
09 
中文品名
“西門子” A型肝炎抗體檢驗試劑組 
英文品名
ADVIA Centaur HAV Total 
藥品類別
B 血液學及病理學裝置 
申請商地址
臺北市南港區園區街3號2樓之2 
通關簽審文件編號
DHA00602140605 
資料更新時間
 
製造商
名稱 廠址 公司地址 國別 製程
SIEMENS HEALTHCARE DIAGNOSTICS INC. 333 CONEY ST. EAST WALPOLE, MA 02032, U.S.A. US
成份表
處方標示 成分名稱 含量 單位
1 &#8226; HAV Total ReadyPack includes :\n(1) Lite Reagent 10.0 ml containing Monoclonal mouse anti-HAV (~0.1 μg/ml) labeled with acridinium ester and biotinylated monoclonal anti-HAV Fab fragment (~0.08 μg/ml) in phosphate buffer with bovine serum albumin, sodium azide (<0.1%) and preservatives.\n(2) Solid phase 17.5 ml containing streptavidin coupled to paramagnetic particles in phosphate buffer with bovine serum albumin, sodium azide (<0.1%) and preservatives.\n(3) Antigen reagent 10.0 ml containingHAV antigen (~0.06 μg/ml) in tricine buffer with bovine serum albumin, stabilizers, sodium azide (<0.1%), and surfactant. \n(4) Ancillary Reagent 25.0 ml containing cysteine in citrate buffer with EDTA and preservatives. \n(5) HAV Total calibrator vials: 2.0 ml/vial processed human plasma positive for anti-HAV antibodies with sodium azide (<0.1%).\n&#8226; HAV Total quality control material containing 7.0 ml/vial processed human plasma negative and positive for Anti-HAV antibodies with sodium azide (<0.1%).\n